VistaGen Therapeutics, Inc. (VSTA) Secures $36 Million to Accelerate Drug Rescue, Predictive Toxicology, and Drug Metabolism Programs
VistaGen Therapeutics, a biotechnology company with stem cell technology designed to improve the predictability of the drug development cycle and…